Recently Viewed

News Announcement

Marksans Pharma: Board Meeting Intimation for Approval Of Audited Financial Results And Dividend

17-May-2023 Follow Value Research Online on Google download pdfDownload PDF Marksans Pharma

MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve the Audited Financial Results of the Company (both Standalone and Consolidated) for the Quarter and Year ended 31st March 2023. The Board of Directors will also consider recommendation of dividend if any for the Financial Year 2022-23.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds